AGIO Competitors & Alternatives
Compare Agios Pharm with similar stocks in the same industry
Biotechnology
AGIO
Main Stock$37.19
Tradestie Score
45
Market Cap
$2.33B
Revenue Growth
2.6%
Analyst Upside
+23.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$32.20
|
$2.37B | 151.8 | 41 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.31
|
$2.34B | - | 39 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$75.03
|
$2.33B | - | 40 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.58
|
$2.23B | - | 52 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.41
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.43
|
$2.21B | - | 75 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.66
|
$2.18B | - | 68 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.55
|
$2.08B | - | 59 | Compare |
More AGIO Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry